MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today ...
The company said, “Recent Highlights: IHL-42X Phase 2 – Statistically significant efficacy, outstanding patient-reported outcomes, and strong safety profile – Incannex (IXHL) reported Phase 2 data for ...
LONDON--(BUSINESS WIRE)--Regulatory News: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today ...
Company establishes two business units with goal of accelerating clinical development of its Radiopharmaceuticals Platform and optimizing the commercial potential of DANYELZA Preliminary Part A data ...
ROCK ISLAND ARSENAL, Ill. – Brig. Gen. John “Brad” Hinson, U.S. Army Sustainment Command commanding general, welcomed Lt. Gen. Chris Mohan, Army Materiel Command deputy commanding general and acting ...
Stocks are fractionally higher Thursday morning after the S&P 500 ended Wednesday in the green. NYSE-listed Bank of America and Morgan Stanley increased share price by over 4% following their latest ...
Hosted on MSN
Samsung Shifts One UI Update Priority to Foldables
For the longest time, Samsung has given its Galaxy S-series of flagship phones priority when it comes to One UI updates. However, the company could be changing that in the future. According to tipster ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback